Veriheal

DECEMBER 15, 2023

How MAPS Plans To Help MAPS has been at the forefront of psychedelic research for decades, funding studies, seminars, and conferences to promote proper education and harm reduction about a myriad of substances. There is still a long way to go, but progress is being made faster than ever before.

Therapy 89

Therapy Decriminalization Treatment Pharmaceutical 89

MMJ Recs

MARCH 20, 2024

These facilities provide a diverse selection of cannabis products, including flower, concentrates, edibles, and topicals, sourced from state-licensed cultivators and manufacturers. Patients first need to obtain a written certification from a qualified healthcare provider confirming their eligibility for medical cannabis treatment.

Dispensary 52

Dispensary Programs Access Patients 52

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. Dispensary Educational Seminars: Many dispensaries in Ohio offer educational seminars and workshops covering topics such as cannabis science, product selection, and consumption methods.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

NOVEMBER 24, 2019

Future studies will explore psilocybin’s effectiveness as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol use in people with major depression. December 3, 2019. December 4, 2019.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). upcoming seminars). 14) and general information or guidelines for practitioners ( n ?=?6). Abbreviations.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

DECEMBER 8, 2021

So, if anyone who knows NORML, probably not surprising that the main topic of this conversation was normalization of cannabis also legalization and something that I found really interesting about the interview with JM was digging into patient rights, and all of the work that NORML does around patient rights in the United States. JMP: Always.

Access 81

Access Policy Patients Cannabis 81